rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Gleevec

Rediff.com  »  News  »   Gleevec

  News for Gleevec

  • Business

Sun Pharma settles litigation with Novartis over cancer drug

Sun Pharma has inked a settlement pact with Novartis Pharmaceutical Corporation over cancer drug Gleevec, paving the way for the Indian drug major to launch a generic version of the medicine in the......

Sun Pharma sues Novartis in US court

In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New......

Novartis denied patent for cancer drug

The Patent Controller Office of India has rejected the patent application of Novartis AG for its cancer drug Gleevec.Assistant Controller of Patents & Designs V Rengasamy rejected the application......

Benefit of Ranbaxy deal to accrue in few years: Sun Pharma

It will take a ‘few years’ for Sun Pharma to realise the benefits of its $4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov, terming the deal as a ‘complex......

Upbeat markets end at record highs ahead of election results

Renewed buying interest in late trades on hopes of BJP-led NDA winning the general elections, results of which are due on Friday pushed the benchmark indices to record closing highs. The 30-share......
  Web results for Gleevec
ESSA Pharma Inc. Announces Appointment of New Director

HOUSTON and VANCOUVER , June 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that it has appointed... ...

http://www.asianhhm.com/pressreleases/essa-pharma-inc-announces-appointment-of-new-director
The Market size of the Oncology Drug Market in Asia - 2019

Asia oncology drugs market research report provides statistics on market revenue, drugs in pipeline, segmentation by generic and patented drugs,... ...

http://pressreleaseping.com/market-size-oncology-drug-market-asia-2019
2015 USTR Special 301 Report Reactions and the way forward

In the aftermath of this year's USTR Special 301 Report, which retained India on the Priority Watch List, industry leaders comment on the Report's... ...

http://www.financialexpress.com/article/pharma/management-pharma/2015-ustr-special-301-report-reactions-and-the-way-forward-2/82186/
Sun Pharmaceutical faces revenue growth challenges

No major product surprises expected from Sun's pipeline for the next 12 months (Photo: Reuters) Sun Pharmaceutical Industries Ltd's Q4FY15... ...

http://www.financialexpress.com/article/markets/indian-markets/sell-rating-on-sun-pharmaceutical-all-round-miss/81539/
Origiin IP Solutions sees 11 drugs going off-patent this year to bolster generic manufacturing prospects in EMs

Origiin IP Solutions LLP has said that 11 drugs of global pharma majors will be going off patent this year and this would augment generic drug... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=88653&sid=1

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages


gleevec
Buy Generic Gleevec Online

For Buying Imatinib & Gleevec Online...
1 Followers

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z